Covered recipient · General Payments record
SAJEDAH TAHER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,131.47
- Reported across 95 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $999.26 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $260.75 | 3 |
| Neurocrine BioSciences, Inc. | $124.95 | 1 |
| Corcept Therapeutics | $100.00 | 1 |
| Arcutis Biotherapeutics, Inc. | $96.88 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $90.39 | 1 |
| SANOFI-AVENTIS U.S. LLC | $85.43 | 1 |
| DEXCOM, INC. | $82.82 | 1 |
| GlaxoSmithKline, LLC. | $38.38 | 2 |
| PFIZER INC. | $37.98 | 2 |
| Novo Nordisk AS | $32.08 | 2 |
| Merck Sharp & Dohme Corporation | $26.25 | 1 |
| Lilly USA, LLC | $23.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $121.12 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108283007 | CMS |
| ABBVIE INC. | $33.94 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108283009 | CMS |
| ABBVIE INC. | $105.69 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108283011 | CMS |
| Arcutis Biotherapeutics, Inc. | $96.88 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121119629 | CMS |
| Boston Scientific Corporation | $90.39 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092439294 | CMS |
| Corcept Therapeutics | $100.00 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117778218 | CMS |
| Dexcom, Inc. | $82.82 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384554 | CMS |
| GlaxoSmithKline, LLC. | $18.49 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116573084 | CMS |
| GlaxoSmithKline, LLC. | $19.89 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116556935 | CMS |
| Lilly USA, LLC | $23.35 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135926820 | CMS |
| Merck Sharp & Dohme LLC | $26.25 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141865459 | CMS |
| Neurocrine Biosciences, Inc. | $124.95 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150921343 | CMS |
| Novo Nordisk Inc | $18.26 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100625148 | CMS |
| Novo Nordisk Inc | $13.82 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100301983 | CMS |
| PFIZER INC. | $15.58 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132021151 | CMS |
| PFIZER INC. | $22.40 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131588315 | CMS |
| SANOFI-AVENTIS U.S. LLC | $85.43 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139888722 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.